US Stock MarketDetailed Quotes

Sagimet Biosciences (SGMT)

Watchlist
  • 7.600
  • -0.050-0.65%
Close May 13 16:00 ET
  • 7.460
  • -0.140-1.84%
Pre 04:51 ET
469.31MMarket Cap-5.63P/E (TTM)

Sagimet Biosciences (SGMT) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-41.04%11.71M
4.47%56.89M
-40.84%10.77M
-15.19%14.33M
12.62%11.93M
126.56%19.87M
66.32%54.45M
92.21%18.2M
78.82%16.9M
50.05%10.59M
Selling and administrative expenses
4.31%4.72M
11.40%17.84M
1.31%4.03M
8.35%4.6M
9.38%4.68M
29.01%4.52M
23.51%16.01M
4.44%3.98M
-5.45%4.25M
79.59%4.28M
-General and administrative expense
4.31%4.72M
11.40%17.84M
1.31%4.03M
8.35%4.6M
9.38%4.68M
29.01%4.52M
23.51%16.01M
4.44%3.98M
-5.45%4.25M
79.59%4.28M
Research and development costs
-54.41%7M
1.59%39.05M
-52.63%6.73M
-23.10%9.73M
14.81%7.25M
191.56%15.34M
94.39%38.44M
151.34%14.22M
155.20%12.65M
35.01%6.31M
Operating profit
41.04%-11.71M
-4.47%-56.89M
40.84%-10.77M
15.19%-14.33M
-12.62%-11.93M
-126.56%-19.87M
-77.14%-54.45M
-92.21%-18.2M
-126.81%-16.9M
-50.05%-10.59M
Net non-operating interest income expense
-37.06%1.06M
-34.16%5.85M
-39.97%1.2M
-37.54%1.43M
-37.72%1.54M
-21.04%1.69M
210.73%8.89M
51.75%1.99M
108.49%2.28M
808.46%2.47M
Non-operating interest income
-37.06%1.06M
-34.16%5.85M
-39.97%1.2M
-37.54%1.43M
-37.72%1.54M
-21.04%1.69M
210.73%8.89M
51.75%1.99M
108.49%2.28M
808.46%2.47M
Other net income (expense)
Income before tax
41.41%-10.65M
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
Income tax
Net income
41.41%-10.65M
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
Net income continuous Operations
41.41%-10.65M
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
Minority interest income
Net income attributable to the parent company
41.41%-10.65M
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
41.41%-10.65M
-12.01%-51.04M
40.94%-9.57M
11.70%-12.91M
-27.94%-10.39M
-174.19%-18.18M
-63.46%-45.57M
-98.76%-16.2M
-130.11%-14.62M
-19.65%-8.12M
Basic earnings per share
41.07%-0.33
-8.97%-1.58
42.00%-0.29
11.11%-0.4
-28.00%-0.32
-143.48%-0.56
45.49%-1.45
-40.45%-0.5
-28.57%-0.45
18.30%-0.25
Diluted earnings per share
41.07%-0.33
-8.97%-1.58
42.00%-0.29
11.11%-0.4
-28.00%-0.32
-143.48%-0.56
45.49%-1.45
-40.45%-0.5
-28.57%-0.45
18.30%-0.25
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -41.04%11.71M4.47%56.89M-40.84%10.77M-15.19%14.33M12.62%11.93M126.56%19.87M66.32%54.45M92.21%18.2M78.82%16.9M50.05%10.59M
Selling and administrative expenses 4.31%4.72M11.40%17.84M1.31%4.03M8.35%4.6M9.38%4.68M29.01%4.52M23.51%16.01M4.44%3.98M-5.45%4.25M79.59%4.28M
-General and administrative expense 4.31%4.72M11.40%17.84M1.31%4.03M8.35%4.6M9.38%4.68M29.01%4.52M23.51%16.01M4.44%3.98M-5.45%4.25M79.59%4.28M
Research and development costs -54.41%7M1.59%39.05M-52.63%6.73M-23.10%9.73M14.81%7.25M191.56%15.34M94.39%38.44M151.34%14.22M155.20%12.65M35.01%6.31M
Operating profit 41.04%-11.71M-4.47%-56.89M40.84%-10.77M15.19%-14.33M-12.62%-11.93M-126.56%-19.87M-77.14%-54.45M-92.21%-18.2M-126.81%-16.9M-50.05%-10.59M
Net non-operating interest income expense -37.06%1.06M-34.16%5.85M-39.97%1.2M-37.54%1.43M-37.72%1.54M-21.04%1.69M210.73%8.89M51.75%1.99M108.49%2.28M808.46%2.47M
Non-operating interest income -37.06%1.06M-34.16%5.85M-39.97%1.2M-37.54%1.43M-37.72%1.54M-21.04%1.69M210.73%8.89M51.75%1.99M108.49%2.28M808.46%2.47M
Other net income (expense)
Income before tax 41.41%-10.65M-12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M
Income tax
Net income 41.41%-10.65M-12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M
Net income continuous Operations 41.41%-10.65M-12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M
Minority interest income
Net income attributable to the parent company 41.41%-10.65M-12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 41.41%-10.65M-12.01%-51.04M40.94%-9.57M11.70%-12.91M-27.94%-10.39M-174.19%-18.18M-63.46%-45.57M-98.76%-16.2M-130.11%-14.62M-19.65%-8.12M
Basic earnings per share 41.07%-0.33-8.97%-1.5842.00%-0.2911.11%-0.4-28.00%-0.32-143.48%-0.5645.49%-1.45-40.45%-0.5-28.57%-0.4518.30%-0.25
Diluted earnings per share 41.07%-0.33-8.97%-1.5842.00%-0.2911.11%-0.4-28.00%-0.32-143.48%-0.5645.49%-1.45-40.45%-0.5-28.57%-0.4518.30%-0.25
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More